PracSys of Salem, NH, last month entered a claim with the American Arbitration Association against North American Scientific regarding a linear accelerator supply deal between the companies that broke down. PracSys filed the complaint on June 16, after
PracSys of Salem, NH, last month entered a claim with the American Arbitration Association against North American Scientific regarding a linear accelerator supply deal between the companies that broke down. PracSys filed the complaint on June 16, after its attempts to resolve a contract dispute with NASI failed.
PracSys and North American Scientific signed a supply deal last year in which North American agreed to pay PracSys $2.7 million for two linear accelerators (SCAN 3/4/98). North American Scientific planned to use the accelerators to produce palladium-103 for the manufacture of prostate brachytherapy seeds.
But the partnership soured six months ago, according to PracSys. The companys complaint states that after the agreement with North American Scientific was signed, NASI signed a contract with another vendor for the supply of palladium, and reneged on its obligation to provide a lease guaranty crucial to the PracSys deal. PracSys claims that North American Scientifics actions prevented it from fulfilling its contract, and the company seeks damages of $3 million.
PracSys claim is meritless, North American Scientific executives told SCAN. In a statement also released June 16, the Chatsworth, CA, company declared that it has realized its obligations under the 1998 contract with PracSys, and announced that it has asked PracSys to turn over the uncompleted linear acceleratorsfor which NASI claims it has paid in full. North American Scientific will install and finish them itself, the company said.
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.